SOX2 and Parkinson disease: For example, a reduced numbers of proliferating cells in the SGZ and SVZ (Höglinger et al., 2004) and a decrease in the number of SOX2 (marker of early NPCs) positive cells were reported in postmortem PD brains (Winner et al., 2012).